These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8564389)

  • 1. Ionophoretic properties of the non-sulfonylurea hypoglycemic agents A-4166 and KAD-1229.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):339-47. PubMed ID: 8564389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionophoretic activity of meglitinide analogues.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Diabetes Res; 1994; 27(2):61-71. PubMed ID: 7671555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. II. Ionophoretic and conformational aspects.
    Malaisse WJ; Nadi AB; Malaisse-Lagae F; Sato F; Lins L; Brasseur R
    Gen Pharmacol; 1995 Oct; 26(6):1319-25. PubMed ID: 7590126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structures and mechanisms for non SU insulin secretagogues].
    Kikuchi M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():362-70. PubMed ID: 12387019
    [No Abstract]   [Full Text] [Related]  

  • 5. Ionophoretic activity of hypoglycemic sulfonylureas.
    Couturier E; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):323-34. PubMed ID: 6250506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.
    Lins L; Brasseur R; Malaisse WJ
    Biochem Pharmacol; 1995 Nov; 50(11):1879-84. PubMed ID: 8615868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats.
    Ichikawa K; Yamato T; Ojima K; Tsuji A; Ishikawa K; Kusama H; Kojima M
    Clin Exp Pharmacol Physiol; 2002; 29(5-6):423-7. PubMed ID: 12010187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Diabetes Res; 1994; 27(2):81-7. PubMed ID: 7671557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells.
    Ohnota H; Kobayashi M; Koizumi T; Katsuno K; Sato F; Aizawa T
    Biochem Pharmacol; 1995 Jan; 49(2):165-71. PubMed ID: 7840793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. I. Secretory and cationic aspects.
    Malaisse WJ; Sato F
    Gen Pharmacol; 1995 Oct; 26(6):1313-8. PubMed ID: 7590125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the nateglinide polymorphism structure and the drug effect.
    Li G; Chen JY; Lü GL; Xu QW
    Yao Xue Xue Bao; 2005 Oct; 40(10):958-60. PubMed ID: 16408818
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effects of hypoglycaemic sulphonylureas and antibiotic ionophores upon calcium translocation.
    Couturier E; Malaisse WJ
    Br J Pharmacol; 1980; 71(1):315-20. PubMed ID: 6781574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis and insulinotropic activity of 2-benzylidenesuccinic acid derivatives].
    Gao LM; Yang P; Song DQ
    Yao Xue Xue Bao; 2005 Dec; 40(12):1122-6. PubMed ID: 16496677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational analysis of the calcium complexes formed by meglitinide analogs.
    Lins L; Brasseur R; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):153-64. PubMed ID: 8581340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of KAD-1229, a nonsulfonylurea hypoglycemic agent, on plasma glucose and insulin in streptozotocin-induced diabetic dogs.
    Misawa K; Ichikawa K; Ojima K; Hamano S; Kitamura T; Komatsu H
    Pharmacology; 2001 Feb; 62(2):65-72. PubMed ID: 11174074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition.
    Fujitani S; Okazaki K; Yada T
    Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new crystal form of nateglinide.
    Li G; Su GQ; Xu QW; Zhu CQ
    Yao Xue Xue Bao; 2001 Jul; 36(7):532-4. PubMed ID: 12585087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nateglinide, a new agent for postprandial glucose control in type 2 diabetes.
    Kotapati S
    Conn Med; 2002 May; 66(5):269-72. PubMed ID: 12071108
    [No Abstract]   [Full Text] [Related]  

  • 19. Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
    Deleers M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic calcium-antagonists and calcium-ionophores.
    Malaisse WJ; Somers G; Valverde I; Couturier E
    Arzneimittelforschung; 1981; 31(4):628-33. PubMed ID: 6264930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.